Altimmune, Inc. (ALT)
NASDAQ: ALT · IEX Real-Time Price · USD
-0.50 (-6.34%)
At close: May 23, 2024, 4:00 PM
+0.09 (1.22%)
After-hours: May 23, 2024, 7:59 PM EDT

Altimmune Statistics

Total Valuation

Altimmune has a market cap or net worth of $523.97 million. The enterprise value is $341.90 million.

Market Cap 523.97M
Enterprise Value 341.90M

Important Dates

The last earnings date was Thursday, May 9, 2024, before market open.

Earnings Date May 9, 2024
Ex-Dividend Date n/a

Share Statistics

Altimmune has 70.90 million shares outstanding. The number of shares has increased by 41.25% in one year.

Shares Outstanding 70.90M
Shares Change (YoY) +41.25%
Shares Change (QoQ) +21.03%
Owned by Insiders (%) 0.78%
Owned by Institutions (%) 63.25%
Float 70.34M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1,277.97
Forward PS n/a
PB Ratio 3.03
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 833.91
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 16.55, with zero debt.

Current Ratio 16.55
Quick Ratio 16.09
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2,727.44

Financial Efficiency

Return on equity (ROE) is -54.20% and return on invested capital (ROIC) is -58.38%.

Return on Equity (ROE) -54.20%
Return on Assets (ROA) -49.50%
Return on Capital (ROIC) -58.38%
Revenue Per Employee $6,949
Profits Per Employee -$1.57M
Employee Count 59
Asset Turnover 0.00
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +66.82% in the last 52 weeks. The beta is 0.20, so Altimmune's price volatility has been lower than the market average.

Beta (1Y) 0.20
52-Week Price Change +66.82%
50-Day Moving Average 8.11
200-Day Moving Average 6.42
Relative Strength Index (RSI) 45.48
Average Volume (30 Days) 4,320,033

Short Selling Information

The latest short interest is 22.31 million, so 31.46% of the outstanding shares have been sold short.

Short Interest 22.31M
Short Previous Month 20.37M
Short % of Shares Out 31.46%
Short % of Float 31.71%
Short Ratio (days to cover) 7.15

Income Statement

In the last 12 months, Altimmune had revenue of $410,000 and -$92.77 million in losses. Loss per share was -$1.61.

Revenue 410,000
Gross Profit 410,000
Operating Income -100.96M
Pretax Income -92.77M
Net Income -92.77M
EBITDA -91.79M
EBIT -92.73M
Loss Per Share -$1.61
Full Income Statement

Balance Sheet

The company has $182.07 million in cash and no debt, giving a net cash position of $182.07 million or $2.57 per share.

Cash & Cash Equivalents 182.07M
Total Debt n/a
Net Cash 182.07M
Net Cash Per Share $2.57
Equity / Book Value 172.94M
Book Value Per Share 2.44
Working Capital 176.18M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$72.76 million and capital expenditures $4,000, giving a free cash flow of -$72.76 million.

Operating Cash Flow -72.76M
Capital Expenditures 4,000
Free Cash Flow -72.76M
FCF Per Share -$1.03
Full Cash Flow Statement


Gross margin is 100.00%, with operating and profit margins of -24,625.37% and -22,626.10%.

Gross Margin 100.00%
Operating Margin -24,625.37%
Pretax Margin -22,626.10%
Profit Margin -22,626.10%
EBITDA Margin -22,388.54%
EBIT Margin -22,617.80%
FCF Margin -17,745.37%

Dividends & Yields

Altimmune does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -41.25%
Shareholder Yield -41.25%
Earnings Yield -17.70%
FCF Yield -13.89%
Dividend Details

Analyst Forecast

The average price target for Altimmune is $17.25, which is 133.42% higher than the current price. The consensus rating is "Buy".

Price Target $17.25
Price Target Difference 133.42%
Analyst Consensus Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 295.77%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on September 14, 2018. It was a reverse split with a ratio of 1:30.

Last Split Date Sep 14, 2018
Split Type Reverse
Split Ratio 1:30


Altimmune has an Altman Z-Score of 16.24 and a Piotroski F-Score of 2.

Altman Z-Score 16.24
Piotroski F-Score 2